This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: National Institute of Health and Medical Research, Biovector Therapeutics, S.a., Centre National De La Recherche Scientifique. Active years: 2002-2018.
Location History:
- Tournefeuille, FR (2002 - 2003)
- Beauzelle, FR (2018)
Company Filing History:
2 out of 1,853 
1 out of 8 
1 out of 5,383 
Years Active: 2002-2018
Title: Innovations of Jean-Luc Davignon
Introduction
Jean-Luc Davignon is a notable inventor based in Tournefeuille, France. He has made significant contributions to the field of medical research, particularly in the development of innovative therapeutic solutions. With a total of 3 patents to his name, his work focuses on addressing inflammatory diseases and advancing vaccine technology.
Latest Patents
Among his latest patents, one includes the development of phosphorylated dendrimers as anti-inflammatory drugs. This invention specifically targets dendrimers with monophosphonic or bisphosphonic terminations for the treatment of inflammatory diseases. Another significant patent involves a fusion protein that comprises the whole or part of the PP65 protein of human cytomegalovirus (CMV). This fusion protein is characterized by its potential use in preparing a vaccine, as it includes at least part of the pp65 protein or a protein with at least 80% homology with it, combined with a second peptide fragment derived from CMV. Additionally, this patent covers a nucleotide sequence coding for such a protein and a pharmaceutical composition containing it, along with its medicinal applications and methods for preparation.
Career Highlights
Throughout his career, Jean-Luc Davignon has worked with esteemed organizations such as the National Institute of Health and Medical Research and Biovector Therapeutics. His experience in these institutions has allowed him to contribute to groundbreaking research and development in the medical field.
Collaborations
He has collaborated with notable colleagues, including Christian Davrinche and Eric Prieur, which has further enriched his research endeavors.
Conclusion
Jean-Luc Davignon's innovative work and patents reflect his commitment to advancing medical science. His contributions are paving the way for new treatments and vaccines that could significantly impact public health.